Tumor-associated macrophages and myeloid-derived suppressor cells contribute to the immunosuppressive TME (tumor microenvironment) by secreting pro-angiogenic factors like VEGFA, promoting angiogenesis and tumor growth, thereby hindering anti-angiogenic therapies [145,146]. The gene discussed is VEGFA; the disease is neoplasm.